Rosetta Genomics Ltd (NASDAQ:ROSG)
| 3.99 Data as of May 23 |  0.00 / 0.00%Today’s Change | 3.09 Today|||52-Week Range 23.43 | -13.82% Year-to-Date |
Latest ROSG News | Press Releases
No recent news for Rosetta Genomics Ltd.
Today’s Trading
| Previous close | 3.99 |
| Today’s open | n.a. |
| Day’s range | -- - -- |
| Volume | 5,459 |
| Average volume (3 months) | 261,144 |
| Market cap | $36.3M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/23/2013
Growth & Valuation
| Earnings growth (last year) | +96.62% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +95.15% |
| P/E ratio | -- |
| Price/Sales | 102.47 |
| Price/Book | 1.17 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GOGCGlobal Green Inc | 0.00 | 0.00% |
| VRNMVerenium Corp | 0.00 | 0.00% |
| BPAXBioSante Pharmaceuti... | 0.00 | 0.00% |
| RPBIFResponse Biomedical ... | 0.00 | 0.00% |
Data as of 4:00pm ET, 05/23/2013
Financials
| Next reporting date | May 30, 2013 |
| EPS forecast (this quarter) | -$0.23 |
| Annual revenue (last year) | $201.0K |
| Annual profit (last year) | -$10.5M |
| Net profit margin | -5,321.39% |
Profile
Sector Health Technology |
Industry Biotechnology |
President & Chief Executive Officer Kenneth A. Berlin |
Chief Financial Officer Ron Kalfus, CPA |
Corporate headquarters Rehovot, -- |
Forecasts
